Methylation-dependent gene silencing induced by interleukin 1β via nitric oxide production

Journal of Experimental Medicine

Volumn 190, Issue 11, 1999, Pages 1595-1603

  Hmadcha, Abdelkrim ^a   Bedoya, Francisco J ^a   Sobrino, Francisco ^a   Pintado, Elizabeth ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

CpG island methylation; FMR1; Gene repression; Interleukin 1 ; Nitric oxide

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVATION; FRAGILE X SYNDROME; GENE EXPRESSION; GENE INDUCTION; GENE SILENCING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL DIVISION; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA PRIMERS; ENZYME ACTIVATION; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE SILENCING; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN-1; JURKAT CELLS; MACROPHAGES; MICE; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; PENICILLAMINE; PROMOTER REGIONS (GENETICS); RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; S-NITROSO-N-ACETYLPENICILLAMINE; TUMOR CELLS, CULTURED;

EID: 0033404952     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.11.1595     Document Type: Article

References (53)

1. Bird, A.P. 1986. CpG islands and the function of DNA methylation. Nature. 321:209-213.
2. Razin, A., and H. Cedar. 1991. DNA methylation and gene expression. Microbiol. Rev. 55:451-458.
3. Bird, A. 1992. The essentials of DNA methylation. Cell. 70:5-8.
4. Tate, P.H., and A.P. Bird. 1993. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3:226-231.
5. Eden, S., and H. Cedar. 1994. Role of DNA methylation in the regulation of transcription. Curr. Opin. Genet. Dev. 4:255-259.
6. Razin, A. 1998. CpG methylation, chromatin structure and gene silencing - a three-way connection. EMBO (Eur. Mol. Biol. Organ.) J. 17:4905-4908.
7. Litt, M.D., R.S. Hansen, I.K. Hornstra, S.M. Gartler, and T.P. Yang. 1997. 5-Azadeoxycytidine-induced chromatin remodeling of the inactive X-linked HPRT gene promoter occurs prior to transcription factor binding and gene reactivation. J. Biol. Chem. 272:14921-14926.
8. Li, E., C. Beard, and R. Jaenish. 1993. Role for DNA methylation in genomic imprinting. Nature. 366:362-365.
9. Marin, M., A. Karis, P. Visser, F. Grosveld, and S. Philipsen. 1997. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell. 89:619-628.
10. Matsuo, K., J. Silke, O. Georgiev, P. Marti, N. Giovannini, and D. Rungger. 1998. An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA. EMBO (Eur. Mol. Biol. Organ.) J. 17:1446-1453.
11. Merlo, A., J.G. Herman, L. Mao, D.J. Lee, E. Gabrielson, P.C. Burger, S.B. Baylin, and D. Sidransky. 1995. CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1:686-692.
12. Laird, P.W., L. Jackson-Grusby, A. Fazeli, S.L. Dickinson, W.E. Jung, E. Li, R.A. Weinberg, and R. Jaenisch. 1995. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 81:197-205.
13. Ramchandani, S., A.R. MacLeod, M. Pinard, E. von Hofe, and M. Szyf. 1997. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA. 94:684-689.
14. Chen, R.Z., U. Pettersson, C. Beard, L. Jackson-Grusby, and R. Jaenish. 1998. DNA hypomethylation leads to elevated mutation rates. Nature. 395:89-92.
15. Oberle, I., F. Rousseau, D. Heitz, C. Kretz, D. Devys, A. Hanauer, J. Boue, M.F. Bertheas, and J.L. Mandel. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 252:1097-1102.
16. Knight, S.J., A.V. Flannery, M.C. Hirst, L. Campbell, Z. Christodoulou, S.R. Phelps, J. Pointon, H.R. Middleton-Price, A. Barnicoat, and M.E. Pembrey. 1993. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 74:127-134.
17. + T cells. J. Exp. Med. 188:103-117.
18. Hmadcha, A., Y. De Diego, and E. Pintado. 1998. Assessment of FMR1 expression by reverse transcriptase-polymerase chain reaction of KH domains. J. Lab. Clin. Med. 131: 170-173.
19. Pintado, E., Y. De Diego, A. Hmadcha, M. Carrasco, J. Sierra, and M. Lucas. 1995. Instability of the CGG repeat at the FRAXA locus and variable phenotypic expression in a large fragile pedigree. J. Med. Genet. 32:907-908.
20. Hallmayer, J., E. Pintado, L. Lotspeich, D. Spiker, W. McMahon, P.B. Petersen, P. Nicholas, C. Pingree, H.C. Kraemer, and D.L. Wong. 1994. Molecular analysis and test of linkage between the FMR-1 gene and infantile autism in multiplex families. Am. J. Hum. Genet. 55:951-959.
21. Adams, R.L., A. Rinaldi, and C. Seivwright. 1991. Microassay for DNA methyltransferase. J. Biochem. Biophys. Methods. 22:19-22.
22. Sobrino, F., A. Gualberto, and E. Pintado. 1988. Regulation of fructose 2,6-bisphosphate levels in cold-acclimated brown adipose tissue of rat. FEBS Lett. 229:91-94.
23. Krebs, A., D. Wiggings, M. Stubbs, A. Sols, and F. Bedoya. 1983. Studies on the mechanism of the antifungal action of benzoate. Biochem. J. 214:657-663.
24. Rousseau, F., D. Heitz, V. Biancalana, S. Blumenfeld, C. Kretz, J. Boue, N. Tommerup, C. Van Der Hagen, C. DeLozier-Blanchet, and M.F. Croquette. 1991. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N. Engl. J. Med. 325:1673-1681.
25. Hagerman, R.J., C.E. Hull, J.F. Safanda, I. Carpenter, L.W. Staley, R.A. O'Connor, C. Seydel, M.M. Mazzocco, K. Snow, and S.N. Thibodeau. 1994. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am. J. Med. Genet. 51:298-308.
26. Stöger, R., T.M. Kajimura, W.T. Brown, and C.D. Laird. 1997. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR 1. Hum. Mol. Genet. 6:1791-1801.
27. Chiurazzi, P., M.G. Pomponi, R. Willemsen, B.A. Oostra, and G. Neri. 1998. In vitro reactivation of the FMR 1 gene involved in fragile X syndrome. Hum. Mol. Genet. 7:109-113.
28. Cetkovic-Cvrlje, M., S. Sandler, and D.L. Eizirik. 1993. Nicotinamide and dexamethasone inhibit interleukin 1-induced nitric oxide production by RINm5F cells without decreasing messenger ribonucleic acid expression for nitric oxide synthase. Endocrinology. 133:1739-1743.
29. Nathan, C. 1992. Nitric oxide as secretory product of mammalian cells. FASEB J. 6:3051-3064.
30. Schwemmle, S., E. de Graaff, H. Deissler, D. Glaser, D. Wohrle, I. Kennerknecht, W. Just, B.A. Oostra, W. Dorfler, W. Vogel, and P. Steinbach. 1997. Characterization of FMR 1 promoter elements by in vivo-footprinting analysis. Am. J. Hum. Genet. 60:1354-1362.
31. Sugiura, Y., and T. Matsumoto. 1995. Nucleotide-selective cleavage of duplex DNA by nitric oxide. Biochem. Biophys. Res. Commun. 211:748-753.
32. Li, E., T.H. Bestor, and R. Jaenisch. 1992. Targeted mutation of DNA methyltransferase gene results in embryonic lethality. Cell. 69:915-926.
33. Bakin, A.V., and T. Curran. 1999. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science. 283: 387-390.
34. Bestor, T.H. 1992. Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO (Eur. Mol. Biol. Organ.) J. 11:2611-2617.
35. Glickman, J.F., J.G. Pavlovich, and N.O. Reich. 1997. Peptide mapping of the murine DNA methyltransferase reveals a major phosphorylation site and the start of translation. J. Biol. Chem. 272:17851-17857.
36. Rouleau, J., A.R. MacLeod, and M. Szyf 1995. Regulation of the DNA-methyltransferase by the ras-Ap-1 signaling pathway. J. Biol. Chem. 270:1595-1601.
37. Okano, M., X. Shaoping, and E. Li. 1998. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19:219-220.
38. Ramchandani, S., S.K. Bhattacharya, N. Cervoni, and M. Szyf. 1999. DNA methylation is a reversible biological signal. Proc. Natl. Acad. Sci. USA. 96:6107-6112.
39. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
40. Bredt, D.S., and S.H. Snyder. 1994. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63:175-195.
41. Avila, M.A., M.V. Carretero, E.N. Rodriguez, and J.M. Mato. 1998. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology. 114:364-371.
42. Flodstrom, M., M.C. Chen, A. Smismans, F. Schuit, D.G. Pipeleers, and D.L. Eizirik. 1999. Interleukin-1β increases arginine accumulation and activates the citrulline-NO cycle in rat pancreatic beta cells. Cytokine. 11:400-407.
43. Luk, W.P., Y. Zhang, T.D. White, F.A. Lue, C. Wu, C.G. Jiang, L. Zhang, and H. Moldofsky. 1999. Adenosine: a mediator of interleukin-1β-induced hippocampal synaptic inhibition. J. Neurosci. 19:4238-4244.
44. Brandeis, M., D. Frank, I. Keshet, Z. Siegfried, M. Mendelsohn, A. Meines, V. Temper, A. Razin, and H. Cedar. 1994. Sp1 elements protect a CpG island from de novo methylation. Nature. 371:435-438.
45. Coffee, B., F. Zhang, S.T. Warren, and D. Reines. 1999. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22:98-101.
46. Kirillov, A., B. Kistler, R. Mostoslavsky, H. Cedar, T. Wirth, and Y. Bergman. 1996. A role for nuclear NF-κB in B-cell-specific demethylation of the IgK locus. Nat. Genet. 13:436-449.
47. Cao, Z., W.J. Henzel, and S. Gao. 1996. IRAK: a kinase associated with the interleukin-1 receptor. Science. 271:1128-1131.
48. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D. Goedel, 1996. TRAF6 is a signal transducer for interleukin-1. Nature. 383:443-446.
49. Imbert, V., R.A. Rupee, A. Livoisi, N.L. Pahi, E.B. Traenckner, C. Mueller-Dieckmann, D. Farahifar, B. Rossi, P. Auberger, P. Baeuerle, and J. Peyron. 1996. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell. 86:787-798.
50. Murata, J., M. Tada, R.D. Iggo, Y. Sawaniura, Y. Shinohe, and H. Abe. 1997. Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutat. Res. 379:211-218.
51. Wink, D.A., K.S. Kasprzak, C.M. Maragos, R.K. Elespuru, M. Misra, T.M. Dunams, T.A. Cebula, W.H. Koch, A.W. Andrews, and J.S. Allen. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254: 1001-1003.
52. Karupiah, G., Q.W. Xie, R.M. Buller, C. Nathan, C. Duarte, and J.D. MacMicking. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science. 261: 1445-1448.
53. Rouleau, J., G. Tanigawa, and M. Szyf. 1992. The mouse DNA methyltransferase 5′-region. A unique housekeeping gene promoter. J. Biol. Chem. 267:7368-7377.